MAIA Biotechnology, Inc. aksje
MAIA
Pre-market$1.3500+0.0500 (+3.85%)
Pre-Market:$1.3640+0.01 (+0.94%)
Laster graf...
MAIA Biotechnology, Inc.
Market Cap
$82,081,024
Åpning1.4000
Høy1.5199
Lav1.3500
Volum3.4M
P/EN/A
Markedsverdi82.08M
52-ukers høy3.1900
52-ukers lav0.8700
Gj.sn. volum743.12k
UtbytteN/A
Beta0.23
EPS-0.6800
Om MAIA Biotechnology, Inc. aksje
MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Selskapsinformasjon
Børs: NYSE American (ASE)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
444 West Lake Street
60606 Chicago, United States
60606 Chicago, United States
Telefon: + 312 416 8592
Nettside: https://maiabiotech.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
10.27
↑ 660.7%
Gjennomsnittlig kursmål
12.14
↑ 798.9%
Median kursmål
12.14
↑ 798.9%
Høyeste kursmål
14.00
↑ 937.0%